Replies to post #124401 on Biotech Values

[mcbio]

David, what are your thoughts on the rest of DNDN's pipeline beyond Provenge? Is it likely that Provenge's MoA makes it amenable to other oncology indications? Is there anything else in the pipeline that sparks your interest?

[bladerunner1717]

Thanks, David. But aren't there other drugs, say Avastin, that are quite expensive on first dose. And what about those hugely expensive drugs from Genzyme? How does reimbusement work for those drugs?

Bladerunner